Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
Oncology Today with Dr Neil Love
Claim This Podcastby Dr. Neil Love
4.8(29 reviews)
602 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
Language
🇺🇲
Publishing Since
4/9/2020
3 verified contact emails on file for Oncology Today with Dr Neil Love
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 21, 2026
EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
<p>Featuring perspectives from Dr Sarah B Goldberg, Dr Jonathan Goldman, Dr Joel W Neal, Dr Antonio Passaro and Dr Jacob Sands, moderated by Dr Sands, including the following topics:</p><ul><li>Introduction<strong> </strong>(00:00)</li><li>Evolving First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) — Prof Passaro (2:27)</li><li>EGFR-Targeted Therapeutic Strategies for Relapsed EGFR-Mutant NSCLC — Dr Neal (36:08)</li><li>Utility of TROP2-Targeted Antibody-Drug Conjugates in the Management of EGFR-Mutant NSCLC — Dr Sands (56:16)</li><li>Emerging Role of Bispecific Antibody-Based Approaches for EGFR-Mutated NSCLC — Dr Goldman (1:19:08)</li><li>Tolerability Considerations with the Use of Available and Emerging Therapies for EGFR-Mutated NSCLC — Dr Goldberg (1:38:46)</li></ul><br/><p><u><a href="https://researchtopractice.com/ASCO2026/EGFRNSCLC/Video" rel="noopener noreferrer" target="_blank">CME information and select publications</a></u></p>
July 20, 2026
Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Dr Neil Love interviews Dr Floor J Backes, Dr Brian M Slomovitz, and Dr Shannon N Westin on current and future approaches to advanced endometrial cancer.
July 17, 2026
HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy
Dr Neil Love interviews Prof Dr Sibylle Loibl about first-line and maintenance therapy advancements for HER2-positive metastatic breast cancer, offering insights into survival gains and treatment strategies.
602 total episodes available with 55 transcripts
Recent guests on Oncology Today with Dr Neil Love
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Floor J Backes
Guest
Brian M Slomovitz
Guest
Shannon N Westin
Guest
Prof Dr Sibylle Loibl
Guest
Farrukh T Awan
Guest
Brad S Kahl
Guest
Robin Klebig
Guest
Mollie Moran
Guest
Dr Ramez N Eskander
Guest
Dr Ursula Matulonis
Guest
Dr Kathleen N Moore
Guest
Dr Alexander B Olawaiye
Guest
Similar Podcasts
Discover related shows you might enjoy
Two Onc Docs
Sam and Karine
ASCO Daily News
American Society of Clinical Oncology (ASCO)
Research To Practice | Oncology Videos
Dr Neil Love
Oncology Brothers
Oncology Brothers
Breast Cancer Update
Dr. Neil Love
OncLive® On Air
OncLive® On Air
The Peter Attia Drive
Peter Attia, MD
Lung Cancer Update
Dr. Neil Love
Gastrointestinal Cancer Update
Dr. Neil Love
Huberman Lab
Scicomm Media
Planet Money
NPR
The Long Run with Luke Timmerman
Timmerman Report
Freakonomics Radio
Freakonomics Radio + Stitcher
Hematologic Oncology Update
Dr. Neil Love
ASCO Guidelines
American Society of Clinical Oncology (ASCO)
Deep-dive analytics for Oncology Today with Dr Neil Love
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Oncology Today with Dr Neil Love?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.